Enchi Liu

Enchi Liu

Company: Tranquis Therapeutics Inc.

Job title: Senior Vice Presidnet - Translational Sciences

Seminars:

Panel Discussion: Looking Beyond Amyloid, Tau, TDP43 & Alpha Synuclein, How Can we Validate Biomarkers for Drugs with Alternative Mechanisms? 3:00 pm

Evaluating how these markers are for TDP43 & Alpha Synuclein across disease? Exploring use cases of biomarker usage for neuroinflammatory pathology, microglia and oxidative stress where there is little relevance to the disease indication Navigating future directions to improve ease of biomarker utility in drug developmentRead more

day: Conference Day 2

Can We Slow Neurodegeneration in Multiple Indications without Reducing Neurofilament Light Chain? 2:00 pm

Reviewing data on NFL in different neurodegenerative diseases Exploring examples of different therapeutic trials where NFL was reduced with treatment response Determining if there are neurodegenerative patient populations for which NFL is not a relevant marker of disease Evaluating feasibility for controlling baseline heterogeneity with NFL for more confident confirmation of efficacy If NFL is…Read more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.